CLINICAL_TRIALS
trial_result
· 2017-08-09
Clinical Trial Update: Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain [Phase 3]
Summary
A Phase 3 study of buprenorphine sublingual spray for postoperative pain was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: INSYS Therapeutics Inc | Conditions: Post-operative Pain | Phase 3 | Status: TERMINATED | Results posted: 2017-08-09